We report here on the generation of a new fluorescent protein reporter transgenic mouse line, Col10a1-mCherry, which can be used as a tool to study chondrocyte biology and pathology. Collagen, Type X, alpha 1 (Col10a1) is highly expressed in hypertrophic chondrocytes and commonly used as a gene marker for this cell population. The Col10a1-mCherry reporter line was generated using a bacterial recombination strategy with the mouse BAC clone RP23-192A7. To aid in the characterization of this animal model, we intercrossed Col10a1-mCherry mice with Collagen, Type II, alpha 1 (Col2a1) enhanced cyan fluorescent protein (ECFP) reporter mice and characterized the expression of both chondrocyte reporters during embryonic skeletal development from days E10.5 to E17.5. Additionally, at postnatal day 0, Col10a1-mCherry reporter expression was compared to endogenous Col10a1 mRNA expression in long bones and revealed that mCherry fluorescence extended past the Col10a1 expression domain. However, in situ hybridization for mCherry was consistent with the zone of Col10a1 mRNA expression, indicating that the persistent detection of mCherry fluorescence was a result of the long protein half life of mCherry in conjunction with a very rapid phase of skeletal growth and not due to aberrant transcriptional regulation. Taking advantage of the continued fluorescence of hypertrophic chondrocytes at the chondro-osseus junction, we intercrossed Col10a1-mCherry mice with two different Collagen, Type 1, alpha 1, (Col1a1) osteoblast reporter mice, pOBCol3.6-Topaz and pOBCol2.3-Emerald to investigate the possibility that hypertrophic chondrocytes transdifferentiate into osteoblasts. Evaluation of long bones at birth suggests that residual hypertrophic chondrocytes and osteoblasts in the trabecular zone exist as two completely distinct cell populations. genesis 49:410-418, 2011. 
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INTRODUCTION
Cartilage formation occurs during endochondral ossification in the appendicular skeleton, axial skeleton and cranial base, where embryonic mesenchyme condenses and differentiates to form a cartilaginous anlagen that, in part, serves as a template for bone formation (Hall and Miyake, 2000) . Signaling between the cartilaginous anlagen and outer perichondrium has been an area of great interest, where morphogenetic changes in the anlagen result in joint formation and bone formation at defined, but disparate locations. During these early stages of skeletal development, chondrocytes organize as a growth plate and undergo a welldefined program of differentiation whose characteristic stages are referred to as: resting or reserve, proliferative, prehypertrophic, and hypertrophic.
Early studies in skeletal biology revealed changes in collagen gene expression during chondrocyte maturation. Collagen, Type 2, alpha 1 (Col2a1) is abundantly expressed in immature chondrocytes, but then down regulated during maturation. In contrast, Collagen, Type 10, alpha 1 (Col10a1) expression is absent in immature chondrocytes, but becomes highly expressed in mature hypertrophic chondrocytes (Castagnola et al., 1988; Iyama et al., 1991 ). An increasing body of evidence has indentified many of the signaling pathways involved in regulating chondrocyte differentiation. Parathyroid hormone related protein (PTHrP) and fibroblast growth factor 18 (FGF18) signaling promote chondrocyte proliferation and block maturation Liu et al., 2002; Vortkamp et al., 1996) while bone morphogenetic protein (BMP), Wnt, and retinoic acid signaling promote chondrocyte maturation in part through runt related transcription factor 2 (RUNX2) Enomoto-Iwamoto et al., 1998; Enomoto et al., 2000; Li et al., 2003; Yasuhara et al., 2010) . Additionally, Indian hedgehog (IHH) functions as a central organizer with direct and indirect roles in chondrocyte proliferation and differentiation, as well as initiating osteoblast differentiation on the outer perichondrium (Kobayashi et al., 2005; Minina et al., 2001 Minina et al., , 2002 St-Jacques et al., 1999; Vortkamp et al., 1996) .
Past studies have sought to define mechanisms of Col10a1 transcriptional regulation. Cis elements providing enhancer and repressor functions have been identified in human, mouse, and chick Col10a1 genes (Beier et al., 1997; Chambers et al., 2002; Harada et al., 1997; Leboy et al., 2001; Riemer et al., 2002; Thomas et al., 1995; Volk et al., 1998) . Additionally, in vitro biochemical studies have revealed a host of factors that are potentially involved in the direct positive regulation of Col10a1 transcription including: RUNX2, AP-1 factors, LEF/TCFs, and SMADs, which are involved in Wnt, BMP, and retinoic acid signaling pathways that promote chondrocyte maturation Enomoto et al., 2000; Gebhard et al., 2008; Li et al., 2003; Riemer et al., 2002; Volk et al., 1998; Yasuhara et al., 2010) . Despite the successful identification of cis and trans regulatory elements required for Col10a1 expression, past transgenic studies that have utilized a defined Col10a1 promoter region to drive the expression of a β-galactosidase reporter or a Cre recombinase suggested additional cis regulatory elements were required to recapitulate endogenous Col10a1 transcription (Gebhard et al., 2004; Yang et al., 2005) . With this in mind, a Col10a1 BAC clone proved sufficient to drive robust and specific expression of a β-galactosidase reporter and a Cre recombinase in hypertrophic chondrocytes (Gebhard et al., 2007 (Gebhard et al., , 2008 .
We report here on the generation and characterization of Col10a1-mCherry fluorescent protein reporter mice. The Col10a1 transgenic construct was created using mouse BAC clone RP23-192A7, which was previously determined to direct accurate expression of Col10a1 (Gebhard et al., 2007 (Gebhard et al., , 2008 . A recombinase A (RecA) bacterial recombination system was used to insert mCherry fluorescent protein just upstream of the translation start site (see Fig. 1 ) (Gong et al., 2002) . Six transgenic founder lines were initially generated.
After a preliminary assessment of reporter gene expression, our two highest expressing lines were maintained thereafter.
To aid in the characterization of Col10a1-mCherry mice, we capitalized on the existence of Col2a1-ECFP and Col1a1 fluorescent protein reporter (pOBCol3.6-Topaz and pOBCol2.3Emerald) mouse lines. Both Col2a1 and Col1a1 reporter mice use fluorescent protein reporters that are spectrally distinct from mCherry allowing us to simultaneously image immature chondrocytes and hypertrophic chondrocytes and/or osteoblasts and hypertrophic chondrocytes, respectively. The generation of Col2a1-ECFP mice was recently reported (Chokalingam et al., 2009a,b) and was constructed in a fashion similar to Col2a1-EGFP mice (Grant et al., 2000) . We characterized the expression of Col10a1-mCherry in relation to Col2a1-ECFP during embryonic skeletal development from E10.5 to E17.5 (see Fig. 2 ). Col2a1-ECFP expression was detected at E10.5, well before Col10a1-mCherry expression in the developing somites, brachial arch 1, and craniofacial primordia covering the ventral forebrain ( Fig. 2A) . At E12.5, Col2a1-ECFP expression defines much of the early-forming axial and appendicular skeleton where condensing vertebral bodies along the axial skeleton and areas of cartilage condensations in both forelimb and hindlimb express the ECFP reporter, but Col10a1-mCherry expression still cannot be observed at this stage ( Fig. 2B ). At E14.5, (Fig. 2C ,D) Col2a1-ECFP expression was seen in the developing ears, ribs, vertebrae, and long bones of the appendicular skeleton. However, expression of the Col2a1 reporter was not observed in the joint spaces and in regions of the anlagen undergoing maturation where Col10a1-mCherry expression was now observed. Both lateral ( Fig. 2C ) and dorsal ( Fig. 2D ) views showed Col10a1 reporter expression in the ribs and at the center of the anlagen in long bones of the appendicular skeleton where chondrocytes undergo hypertrophy. By E17.5 ( Fig. 2E -H) Col2a1 and Col10a1 driven reporter genes sharply illuminated much of the embryonic skeleton. Col2a1 reporter expression was seen in the ears and cranial base of the skull, in the ventral part of the rib cage and vertebral bodies of the spine, and at the proximal and distal ends of long bones of the appendicular skeleton (Fig. 2E ,G,H, blue). Col10a1 reporter expression was observed in the dorsal half of the rib cage and in symmetrical points of hypertrophy along the vertebrae (Fig. 2F,H, red) . In the long bones of the appendicular skeleton, Col10a1 reporter expression domains lay adjacent and interior to Col2a1 expressing chondrocytes (Fig. 2F,G) . To appreciate the temporal changes that occur during long bone formation, we imaged forearm development at higher magnification from E12.5 to E17.5 (Fig. 2I-K) . At E12.5 Col2a1-ECFP expression can be observed at sites of chondrocyte condensation (Fig. 2I) . At E14.5, a single Col10a1-mCherry expression zone was seen at the center of anlagen in the humerus, radius, ulna, and digits ( Fig. 2J) . By E17.5 the Col10a1 expression zone has separated into two domains with a gap in between where hypertrophic chondrocytes are undergoing apoptosis, promoting the formation of a marrow cavity, and leaving a mineralized template upon which trabecular bone will form (Fig. 2K) . Tissue sections through the forearm of E17.5 mice (Fig. 2L-O) showed some overlapping expression between Col2a1 and Col10a1 reporters in the growth plate (Fig. 2O) . Col2a1 reporter expression can be seen throughout the resting and proliferative zones, but was down regulated in the hypertrophic zone (Fig. 2L ). Col10a1 reporter expression is absent from the resting and proliferative zones, but robustly expressed in chondrocytes undergoing hypertrophy (Fig. 2M) .
To further characterize the expression of Col10a1-mCherry reporter mice, we compared reporter gene expression to endogenously expressed Col10a1 mRNA at postnatal day 0 (P0) in long bones (Fig. 3, compare A with B) . As anticipated, endogenous Col10a1 mRNA was largely restricted to the hypertrophic zone (HZ) (Fig. 3B, tibia) . Interestingly, while Col10a1-mCherry reporter expression was detected in the hypertrophic zone, the fluorescence of the reporter actually intensified as hypertrophic cells became part of the bone marrow (BM) (Fig. 3A) . To clarify whether this was aberrant transcriptional regulation of our transgenic DNA construct, we carried out an in situ for mCherry mRNA (Fig. 3D,  fibula) . However, mCherry mRNA expression was largely restricted to the hypertrophic zone like Col10a1 mRNA, while mCherry protein fluorescence extended from the hypertrophic zone into the bone marrow (Fig. 3C) . On the other hand, at adult ages mCherry fluorescence is largely restricted to the hypertrophic zone and substantially less is observed in the bone marrow trabecular region (data not shown). Therefore, we conclude that the transcriptional regulation of our reporter is accurate, but the long protein half-life of mCherry (~24 hours) allows for the continued marking of hypertrophic chondrocytes at a very active stage of skeletal growth. Consistent with hypertrophic chondrocytes undergoing programmed cell death, much of the mCherry fluorescence we observed in the bone marrow appeared as cell debris particularly as the distance from the growth plate into the bone marrow space increased (Fig. 3E, white arrows) . However, we also observed a diverse range of cellular phenotypes that we speculate are hypertrophic cells at different stages of cell death. Among this complex environment, we occasionally observed mCherry positive cells within the trabecular region that looked relatively intact, retained nuclei as determined by DAPI staining, and showed high mCherry fluorescence (Fig. 3E , and imaged at lower exposure in Fig. 3F , cells marked by an asterisk). Previous studies have also commented on the existence of hypertrophic chondrocytes that seem to evade apoptosis (Gebhard et al., 2007) . While the reason for increased mCherry fluorescence as hypertrophic chondrocytes meet and mix with bone marrow cells is not clear, we speculate that it is related to the changing physiology of hypertrophic chondrocytes.
The continued marking of intact hypertrophic chondrocytes within the trabecular region of bone by the mCherry reporter suggested the possibility that these cells may be a rare population of hypertrophic chondrocytes that further differentiate into osteoblasts as an alternative to apoptosis. The topic of hypertrophic chondrocytes differentiating into osteoblasts has been speculated upon for years (Kahn and Simmons, 1977; Moskalewski and Malejczyk, 1989; Thesingh et al., 1991) and has been the subject of different review articles (Adams and Shapiro, 2002; Shapiro et al., 2005; Wlodarski et al., 2006) . To explore the possibility of chondrocyte to osteoblast transdifferentiation, we crossed Col10a1-mCherry mice with two different osteoblast reporter mouse lines, pOBCol3.6-Topaz and pOBCol2.3-Emerald (see Fig. 4 ), which have been extensively used to study osteoblast biology (BilicCurcic et al., 2005; Kalajzic et al., 2002 Kalajzic et al., , 2005 Ushiku et al., 2010) . We reasoned that the persistent detection of Col10a1-mCherry fluorescence in cells present within the trabecular bone region may be used in a developmental fate mapping-like scheme and allow us to detect skeletal cells that express both chondrocyte and osteoblast reporters. However, examination of long bones at P0 from triple (Col2a1-ECFP, Col10a1-mCherry, and pOBCol3.6-Topaz) (Fig. 4A-D) and dual (Col10a1-mCherry and pOBCol2.3-Emerald) (Fig.  4E-H ) transgenic mice showed no evidence of cell populations expressing both chondrocyte and osteoblast reporters. While Col10a1-mCherry positive cells (Fig. 4B,F , yellow arrow heads) and pOBCol3.6-Topaz (Fig. 4C ) or pOBCol2.3-Emerald (Fig. 4G) positive osteoblasts (white arrow heads) could be seen amongst each other (Fig. 4D,H) , both cell populations were entirely distinct. Since this is not a true genetic fate mapping scheme, we cannot completely rule out the possibility of transdifferentiation. However, given the clear distinction of chondrocyte and osteoblast cell types at this very active stage of skeletal development, we believe that transdifferentiation is unlikely to be a natural process.
Numerous pathological conditions exist that directly involve cartilage, including genetically inherited disorders, sports induced injuries, and age related deterioration. Genetic manipulation of the mouse is a common strategy to study gene function, to model different pathological conditions, and to test regenerative therapies. Here we have introduced the generation Col10a1-mCherry transgenic reporter mice that will serve as a valuable tool to study chondrocyte development, damage, and repair. To aid in the characterization of this animal model and increase our understanding of chondrocyte biology, we crossed Col10a1-mCherry mice with Col2a1-ECFP, pOBCol3.6-Topaz, and pOBCol2.3-Emerald mice. The combinatorial use of spectrally-distinct fluorescent protein reporters enables the intercrossing of different fluorescent protein reporter lines to further resolve cell types, mechanisms of development, and tissue regeneration.
MATERIALS AND METHODS

DNA Constructs
BAC Clone RP23-192A7 was obtained from Children's Hospital Research Institute (CHORI). PLD53.SC2 and PSV1.RecA vectors were kindly provided by Shiaoching Gong (Gong et al., 2002) .
Assembly of the Col10a1-mCherry Reporter
A 453bp homology arm was PCR amplified from purified RP23-192A7 using primers: Col10a1 5′Not1 (Sense) 5′-TCTCGCGGCCGCGTACCCAGACAGGTTCATTTGT ATTGATCT-3′ and Col10a1 3′ BamH1 (antisense) 5′-CTCTGGATCCTTTCAGATAGATTCTGAAAAGCAGAAGA GAATC-3′. The PCR amplicon was cloned into Not1 and BamH1 sites of the pLD53.sc2-mCherry shuttle vector using standard cloning methods. Recombinase A was introduced into RP23-192A7 host bacteria by transformation with pSV1.RecA vector (100 ng) and selected for on chloramphenicol (12.5 ug/ml)/tetracycline (10ug/ml) LB agar plates. RP23-192A7 host bacteria containing RecA were then transformed by electroporation with 1 μg (1-2 μl) of the pLD53.sc2-mCherry containing the Col10a1 homology arm. SOC medium (1 ml) was added and transformed bacteria were incubated with shaking at 200 rpm for one hour at 30°C. Recombinants were first selected for by adding 5 ml of LB medium containing chloramphenicol (12.5 μg/ml), ampicillin (50 μg/ml), and tetracycline (10 μg/ml) to bacteria and grown overnight at 30°C with shaking at 200 rpm. Further selection for recombinant clones was carried out by plating 100 μl of overnight culture on to chloramphenicol (12.5 μg/ml), ampicillin (50 μg/ml) LB agar plates and incubated overnight at 42°C. Chloramphenicol/ampicillin resistant colonies were screened by colony PCR using primers that flank the Col10a1 homology arm: Col10a1 5′ Recom (sense) 5′-CCTGCCAGCAGGCTTGGAAACAGGCTTCA-3′ and mCherry 3′ (antisense) 5′-GCACCTTGAAGCGCATGAACTCCTTGATGA-3′. Colony PCR identified candidate recombinants were further verified by diagnostic restriction enzyme digestion with Sal1 and Pvu1 and field inversion gel electrophoresis.
BAC DNA Preparation for Pronuclear Injection
The Col10a1-mCherry BAC construct was purified from a 200-ml culture using a Maxi Kit (Qiagen) with minor modifications. During alkaline lysis, 2M potassium acetate was used in place of the 3M solution. Additionally, after elution with QF buffer, two phenol/chloroform extractions followed by one chloroform extraction were carried out to further clean up the BAC DNA. BAC DNA (10 μg) was then linearized with PI-SceI restriction enzyme for 2 hours and loaded onto a CL-4B Sepharose (Sigma) column pre-equilibrated with injection buffer (10 mM Tris, pH7.5, 0.1 mM EDTA, 100 mM NaCl). Ten 300 μl fractions were collected from the column and DNA concentrations were measured with a Nanodrop Spectrophotometer (Thermo-Scientific). Thirty microliters of each fraction were also run on a field inversion gel to assess the DNA quality. Pronuclear injection was carried out at the UCONN Health Center Gene Targeting and Transgenic Facility.
Probe Synthesis for In Situ Hybridization
BAC clone RP23-192A7 containing the Col10a1 gene and PLD53.sc2-mCherry plasmid were used to synthesize a Col10a1 probe (733 bp) and mCherry probe (741 bp), respectively. PCR primers for Col10a1 were: sense, 5′-GTAGGAGCTAAAGGAGTGCCTGGACAC-3′;
anti-sense, 5′-GTGAGGAAACTTGGTCCCAGAGTGCAC-3′ and nested oligo, anti-sense, 5′-ACGAGTGGACGTACTCAGAGGAGTAG-3′. PCR primers for mCherry were: sense, 5′-GGAG GATAACATGGCCATCATCAAGG-3′; anti-sense, 5′-CGTAC TGTTCCACGATGGTGTAGTCCTCG-3′. The final PCR reaction for probe synthesis was done only with the antisense oligo to generate single-stranded DNA (ssDNA) probes in the presence of digoxigenin-11-dUTP (Roche) as previously described (O'Connell, 2002) . Synthesized probes were further cleaned up using PCR purification columns (Qiagen).
In Situ Hybridization
Frozen tissue sections were first fixed in 4% paraformaldehyde (PFA) at room temperature for 10 min and then incubated in 3% H 2 O 2 /PBS for 10 min to quench endogenous peroxidase activity. After proteinase K treatment (1 μg/ml in Tris-HCl/0.05M EDTA) for 10 min, sections were further permeabilized in 0.1% Triton X-100 for 10 min. Sections were then refixed in 4% PFA for 5 min. Sections were washed three times (5 min/wash) with PBS and dehydrated in 70% ethanol for 5 min followed by brief washes in 80%, 90%, and 100% ethanol before hybridization. Hybridization buffer: (50% formamide, 10% dextran sulfate, 1% Denhardt's, 250 μg/ml yeast tRNA, 0.3M NaCl, 20mM Tris-Cl (pH 8.0), 5mM EDTA (pH 8.0), 10mM NaPO 4 (pH 8.0), 1% Sarkosyl). Single-stranded DNA probes were diluted in hybridization buffer (1:200). Hybridization was then carried out in a humidified chamber at 55°C for 18 hours. After hybridization sections went through sequential wash steps: 30 min in 50% formamide in 2× SSC at 65°C, 15 min in 2× SSC at 37°C, 15 min in 0.1× SSC at 37°C, and 15 min in TNT buffer (0.1M Tris-Cl pH 7.5, 0.15M NaCl, and 0.05% Tween-20). After blocking in 0.5% blocking reagent (PerkinElmer, FP1020) in TNT buffer for 1 hour, the hybridized ssDNA probes were detected by incubating 30 min with antidigoxigenin-POD, Fab fragment (1:100) (Roche). Digoxigenin labeled probe was detected by incubating 10 min in 1:50 TSA plus Fluorescein (PerkinElmer) and washed three times in TNT buffer before visualization.
Imaging of Reporter Gene Mice
Whole embryo imaging was carried out on a Zeiss Lumar stereomicroscope. Tissues sections were imaged using a Zeiss Imager Z.1 upright microscope. 
